The Office of Science Policy (OSP): · Advises the NIH Director on science policy issues affecting the medical research community · Participates in the development of new policy and program initiatives · Monitors and coordinates agency planning and evaluation activities · Plans and implements a comprehensive science education program · Develops and implements NIH policies and procedures for the safe conduct of recombinant DNA and other biotechnology activities Office of Science Policy (OSP) Lana R. Skirboll, Ph.D., Director Office of Biotechnology Activities (OBA) Amy P. Patterson, M.D., Director Evaluation Branch (EB) Juliana M. Blome, Ph.D., Acting Chief Office of Science Education (OSE) Bruce A. Fuchs, Ph.D., Director Office of Science Policy Analysis (OSPA) Lynn Hudson, Ph.D. Acting Director Program on Public-Private Partnerships           Barbara Mittleman, M.D., Director Clinical Research Policy Analysis and Coordination Program (CRpac) Amy P. Patterson, M.D., Director Contact OSP: Office of Science Policy, OD, NIH Building 1, Room 103 9000 Rockville Pike Bethesda, MD 20892 (301) 496-2122 (phone) (301) 402-1759 (fax)

National Institutes of Health (NIH) Bethesda, Maryland 20892

Department of Health and Human Services